Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3295 entries
Sorted by: Best Match Show Resources per page
Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System.

Frontiers in cardiovascular medicine

Zeller T, Seiffert M, Müller C, Scholz M, Schäffer A, Ojeda F, Drexel H, Mündlein A, Kleber ME, März W, Sinning C, Brunner FJ, Waldeyer C, Keller T, Saely CH, Sydow K, Thiery J, Teupser D, Blankenberg S, Schnabel R.
PMID: 28979897
Front Cardiovasc Med. 2017 Sep 20;4:57. doi: 10.3389/fcvm.2017.00057. eCollection 2017.

Coronary artery disease (CAD) has a complex etiology involving numerous environmental and genetic factors of disease risk. To date, the genetic 9p21 locus represents the most robust genetic finding for prevalent and incident CAD. However, limited information is available...

Cite
Zeller T, Seiffert M, Müller C, et al. Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System. Front Cardiovasc Med. 2017;4:57doi: 10.3389/fcvm.2017.00057.
Zeller, T., Seiffert, M., Müller, C., Scholz, M., Schäffer, A., Ojeda, F., Drexel, H., Mündlein, A., Kleber, M. E., März, W., Sinning, C., Brunner, F. J., Waldeyer, C., Keller, T., Saely, C. H., Sydow, K., Thiery, J., Teupser, D., Blankenberg, S., & Schnabel, R. (2017). Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System. Frontiers in cardiovascular medicine, 457. https://doi.org/10.3389/fcvm.2017.00057
Zeller, Tanja, et al. "Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System." Frontiers in cardiovascular medicine vol. 4 (2017): 57. doi: https://doi.org/10.3389/fcvm.2017.00057
Zeller T, Seiffert M, Müller C, Scholz M, Schäffer A, Ojeda F, Drexel H, Mündlein A, Kleber ME, März W, Sinning C, Brunner FJ, Waldeyer C, Keller T, Saely CH, Sydow K, Thiery J, Teupser D, Blankenberg S, Schnabel R. Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System. Front Cardiovasc Med. 2017 Sep 20;4:57. doi: 10.3389/fcvm.2017.00057. eCollection 2017. PMID: 28979897; PMCID: PMC5611399.
Copy Download .nbib Format: NLM
Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature.

Frontiers in cardiovascular medicine

Narang N, Lang RM, Liarski VM, Jeevanandam V, Hofmann Bowman MA.
PMID: 28396860
Front Cardiovasc Med. 2017 Mar 27;4:14. doi: 10.3389/fcvm.2017.00014. eCollection 2017.

A 55-year-old man with a history of erosive, seropositive rheumatoid arthritis (RA), and interstitial lung disease presented with shortness of breath. Echocardiography showed new-onset severe left ventricular (LV) dysfunction with an ejection fraction (EF) of 15% and moderately increased...

Cite
Narang N, Lang RM, Liarski VM, et al. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Front Cardiovasc Med. 2017;4:14doi: 10.3389/fcvm.2017.00014.
Narang, N., Lang, R. M., Liarski, V. M., Jeevanandam, V., & Hofmann Bowman, M. A. (2017). Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Frontiers in cardiovascular medicine, 414. https://doi.org/10.3389/fcvm.2017.00014
Narang, Nikhil, et al. "Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature." Frontiers in cardiovascular medicine vol. 4 (2017): 14. doi: https://doi.org/10.3389/fcvm.2017.00014
Narang N, Lang RM, Liarski VM, Jeevanandam V, Hofmann Bowman MA. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Front Cardiovasc Med. 2017 Mar 27;4:14. doi: 10.3389/fcvm.2017.00014. eCollection 2017. PMID: 28396860; PMCID: PMC5366320.
Copy Download .nbib Format: NLM
Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent .

Frontiers in cardiovascular medicine

Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC.
PMID: 28421185
Front Cardiovasc Med. 2017 Apr 04;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017.

The microbiome is increasingly recognized as an important influence on human health and many of the comorbidities that affect patients after solid organ transplantation (SOT) have been shown to involve changes in gut bacterial populations. Thus, microbiome changes in...

Cite
Flannigan KL, Rajbar T, Moffat A, et al. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Front Cardiovasc Med. 2017;4:17doi: 10.3389/fcvm.2017.00017.
Flannigan, K. L., Rajbar, T., Moffat, A., McKenzie, L. S., Dicke, F., Rioux, K., Workentine, M. L., Louie, T. J., Hirota, S. A., & Greenway, S. C. (2017). Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Frontiers in cardiovascular medicine, 417. https://doi.org/10.3389/fcvm.2017.00017
Flannigan, Kyle L, et al. "Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent ." Frontiers in cardiovascular medicine vol. 4 (2017): 17. doi: https://doi.org/10.3389/fcvm.2017.00017
Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Front Cardiovasc Med. 2017 Apr 04;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017. PMID: 28421185; PMCID: PMC5378704.
Copy Download .nbib Format: NLM
Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique.

Frontiers in cardiovascular medicine

Azevedo AI, Braga P, Rodrigues A, Ferreira N, Fonseca M, Dias A, Gama Ribeiro V.
PMID: 27703967
Front Cardiovasc Med. 2016 Sep 20;3:32. doi: 10.3389/fcvm.2016.00032. eCollection 2016.

Thoracic endovascular aortic repair (TEVAR) is increasingly used in the treatment of acute type B aortic dissection. Type Ia endoleaks are a common complication of the procedure, but its clinical significance and the best treatment strategy remain poorly defined....

Cite
Azevedo AI, Braga P, Rodrigues A, et al. Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique. Front Cardiovasc Med. 2016;3:32doi: 10.3389/fcvm.2016.00032.
Azevedo, A. I., Braga, P., Rodrigues, A., Ferreira, N., Fonseca, M., Dias, A., & Gama Ribeiro, V. (2016). Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique. Frontiers in cardiovascular medicine, 332. https://doi.org/10.3389/fcvm.2016.00032
Azevedo, Ana Isabel, et al. "Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique." Frontiers in cardiovascular medicine vol. 3 (2016): 32. doi: https://doi.org/10.3389/fcvm.2016.00032
Azevedo AI, Braga P, Rodrigues A, Ferreira N, Fonseca M, Dias A, Gama Ribeiro V. Persistent Type I Endoleak after Endovascular Treatment with Chimney Technique. Front Cardiovasc Med. 2016 Sep 20;3:32. doi: 10.3389/fcvm.2016.00032. eCollection 2016. PMID: 27703967; PMCID: PMC5028720.
Copy Download .nbib Format: NLM
Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal.

Frontiers in cardiovascular medicine

Devkota S, Dhungana RR, Pandey AR, Bista B, Panthi S, Thakur KK, Gajurel RM.
PMID: 27532038
Front Cardiovasc Med. 2016 Aug 02;3:26. doi: 10.3389/fcvm.2016.00026. eCollection 2016.

INTRODUCTION: Despite the established evidence on benefits of controlling raised blood pressure and development of several guidelines on detection and management of hypertension, people often have untreated or uncontrolled hypertension. In this context, we undertook this study to identify...

Cite
Devkota S, Dhungana RR, Pandey AR, et al. Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal. Front Cardiovasc Med. 2016;3:26doi: 10.3389/fcvm.2016.00026.
Devkota, S., Dhungana, R. R., Pandey, A. R., Bista, B., Panthi, S., Thakur, K. K., & Gajurel, R. M. (2016). Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal. Frontiers in cardiovascular medicine, 326. https://doi.org/10.3389/fcvm.2016.00026
Devkota, Surya, et al. "Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal." Frontiers in cardiovascular medicine vol. 3 (2016): 26. doi: https://doi.org/10.3389/fcvm.2016.00026
Devkota S, Dhungana RR, Pandey AR, Bista B, Panthi S, Thakur KK, Gajurel RM. Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal. Front Cardiovasc Med. 2016 Aug 02;3:26. doi: 10.3389/fcvm.2016.00026. eCollection 2016. PMID: 27532038; PMCID: PMC4969292.
Copy Download .nbib Format: NLM
Thrombosis - Besieged but Poorly Understood.

Frontiers in cardiovascular medicine

Lang IM.
PMID: 26664856
Front Cardiovasc Med. 2014 Aug 18;1:4. doi: 10.3389/fcvm.2014.00004. eCollection 2014.

No abstract available.

Cite
Lang IM. Thrombosis - Besieged but Poorly Understood. Front Cardiovasc Med. 2014;1:4doi: 10.3389/fcvm.2014.00004.
Lang, I. M. (2014). Thrombosis - Besieged but Poorly Understood. Frontiers in cardiovascular medicine, 14. https://doi.org/10.3389/fcvm.2014.00004
Lang, Irene M. "Thrombosis - Besieged but Poorly Understood." Frontiers in cardiovascular medicine vol. 1 (2014): 4. doi: https://doi.org/10.3389/fcvm.2014.00004
Lang IM. Thrombosis - Besieged but Poorly Understood. Front Cardiovasc Med. 2014 Aug 18;1:4. doi: 10.3389/fcvm.2014.00004. eCollection 2014. PMID: 26664856; PMCID: PMC4668866.
Copy Download .nbib Format: NLM
Advancing and Translating Knowledge in Vascular Medicine.

Frontiers in cardiovascular medicine

Husmann M, Barton M.
PMID: 26664857
Front Cardiovasc Med. 2014 Oct 29;1:6. doi: 10.3389/fcvm.2014.00006. eCollection 2014.

For centuries, physicians have depended on the use of written information to gain knowledge. Book printing and binding introduced by Gutenberg in the fifteenth century revolutionized and accelerated the distribution of information. Advancing medical knowledge and progress is not...

Cite
Husmann M, Barton M. Advancing and Translating Knowledge in Vascular Medicine. Front Cardiovasc Med. 2014;1:6doi: 10.3389/fcvm.2014.00006.
Husmann, M., & Barton, M. (2014). Advancing and Translating Knowledge in Vascular Medicine. Frontiers in cardiovascular medicine, 16. https://doi.org/10.3389/fcvm.2014.00006
Husmann, Marc, and Barton, Matthias. "Advancing and Translating Knowledge in Vascular Medicine." Frontiers in cardiovascular medicine vol. 1 (2014): 6. doi: https://doi.org/10.3389/fcvm.2014.00006
Husmann M, Barton M. Advancing and Translating Knowledge in Vascular Medicine. Front Cardiovasc Med. 2014 Oct 29;1:6. doi: 10.3389/fcvm.2014.00006. eCollection 2014. PMID: 26664857; PMCID: PMC4668854.
Copy Download .nbib Format: NLM
Dual Linkage of a Locus to Left Ventricular Mass and a Cardiac Gene Co-Expression Network Driven by a Chromosome Domain.

Frontiers in cardiovascular medicine

Scott-Boyer MP, Praktiknjo SD, Llamas B, Picard S, Deschepper CF.
PMID: 26664861
Front Cardiovasc Med. 2014 Dec 10;1:11. doi: 10.3389/fcvm.2014.00011. eCollection 2014.

We have previously reported Lvm1 as a quantitative trait locus (QTL) on chromosome 13 that links to cardiac left ventricular mass (LVM) in a panel of AxB/BxA mouse recombinant inbred strains (RIS). When performing a gene expression QTL (eQTL)...

Cite
Scott-Boyer MP, Praktiknjo SD, Llamas B, et al. Dual Linkage of a Locus to Left Ventricular Mass and a Cardiac Gene Co-Expression Network Driven by a Chromosome Domain. Front Cardiovasc Med. 2014;1:11doi: 10.3389/fcvm.2014.00011.
Scott-Boyer, M. P., Praktiknjo, S. D., Llamas, B., Picard, S., & Deschepper, C. F. (2014). Dual Linkage of a Locus to Left Ventricular Mass and a Cardiac Gene Co-Expression Network Driven by a Chromosome Domain. Frontiers in cardiovascular medicine, 111. https://doi.org/10.3389/fcvm.2014.00011
Scott-Boyer, Marie-Pier, et al. "Dual Linkage of a Locus to Left Ventricular Mass and a Cardiac Gene Co-Expression Network Driven by a Chromosome Domain." Frontiers in cardiovascular medicine vol. 1 (2014): 11. doi: https://doi.org/10.3389/fcvm.2014.00011
Scott-Boyer MP, Praktiknjo SD, Llamas B, Picard S, Deschepper CF. Dual Linkage of a Locus to Left Ventricular Mass and a Cardiac Gene Co-Expression Network Driven by a Chromosome Domain. Front Cardiovasc Med. 2014 Dec 10;1:11. doi: 10.3389/fcvm.2014.00011. eCollection 2014. PMID: 26664861; PMCID: PMC4668859.
Copy Download .nbib Format: NLM
The Challenges of Arterial Hypertension.

Frontiers in cardiovascular medicine

Rossi GP.
PMID: 26664874
Front Cardiovasc Med. 2015 Feb 03;2:2. doi: 10.3389/fcvm.2015.00002. eCollection 2015.

No abstract available.

Cite
Rossi GP. The Challenges of Arterial Hypertension. Front Cardiovasc Med. 2015;2:2doi: 10.3389/fcvm.2015.00002.
Rossi, G. P. (2015). The Challenges of Arterial Hypertension. Frontiers in cardiovascular medicine, 22. https://doi.org/10.3389/fcvm.2015.00002
Rossi, Gian Paolo. "The Challenges of Arterial Hypertension." Frontiers in cardiovascular medicine vol. 2 (2015): 2. doi: https://doi.org/10.3389/fcvm.2015.00002
Rossi GP. The Challenges of Arterial Hypertension. Front Cardiovasc Med. 2015 Feb 03;2:2. doi: 10.3389/fcvm.2015.00002. eCollection 2015. PMID: 26664874; PMCID: PMC4668841.
Copy Download .nbib Format: NLM
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!.

Frontiers in cardiovascular medicine

Maiolino G, Azzolini M, Rossi GP.
PMID: 26664875
Front Cardiovasc Med. 2015 Feb 04;2:3. doi: 10.3389/fcvm.2015.00003. eCollection 2015.

Despite the availability of anti-hypertensive medications with increasing efficacy up to 50% of hypertensive patients have blood pressure levels (BP) not at the goals set by international societies. Some of these patients are either not optimally treated or are...

Cite
Maiolino G, Azzolini M, Rossi GP. Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!. Front Cardiovasc Med. 2015;2:3doi: 10.3389/fcvm.2015.00003.
Maiolino, G., Azzolini, M., & Rossi, G. P. (2015). Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!. Frontiers in cardiovascular medicine, 23. https://doi.org/10.3389/fcvm.2015.00003
Maiolino, Giuseppe, et al. "Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!." Frontiers in cardiovascular medicine vol. 2 (2015): 3. doi: https://doi.org/10.3389/fcvm.2015.00003
Maiolino G, Azzolini M, Rossi GP. Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!. Front Cardiovasc Med. 2015 Feb 04;2:3. doi: 10.3389/fcvm.2015.00003. eCollection 2015. PMID: 26664875; PMCID: PMC4668865.
Copy Download .nbib Format: NLM
Improved Right Ventricular Performance with Increased Tricuspid Annular Excursion in Athlete's Heart.

Frontiers in cardiovascular medicine

Zha W, Schiros CG, Reddy G, Feng W, Denney TS, Lloyd SG, Dell'Italia LJ, Gupta H.
PMID: 26664880
Front Cardiovasc Med. 2015 Apr 30;2:8. doi: 10.3389/fcvm.2015.00008. eCollection 2015.

BACKGROUND: Marathon runners (MTH) and patients with mitral regurgitation (MR) exhibit left ventricular (LV) overload, and LV geometric changes in these groups have been reported. In this study, right ventricular (RV) adaptation to chronic volume overload was evaluated in...

Cite
Zha W, Schiros CG, Reddy G, et al. Improved Right Ventricular Performance with Increased Tricuspid Annular Excursion in Athlete's Heart. Front Cardiovasc Med. 2015;2:8doi: 10.3389/fcvm.2015.00008.
Zha, W., Schiros, C. G., Reddy, G., Feng, W., Denney, T. S., Lloyd, S. G., Dell'Italia, L. J., & Gupta, H. (2015). Improved Right Ventricular Performance with Increased Tricuspid Annular Excursion in Athlete's Heart. Frontiers in cardiovascular medicine, 28. https://doi.org/10.3389/fcvm.2015.00008
Zha, Wei, et al. "Improved Right Ventricular Performance with Increased Tricuspid Annular Excursion in Athlete's Heart." Frontiers in cardiovascular medicine vol. 2 (2015): 8. doi: https://doi.org/10.3389/fcvm.2015.00008
Zha W, Schiros CG, Reddy G, Feng W, Denney TS, Lloyd SG, Dell'Italia LJ, Gupta H. Improved Right Ventricular Performance with Increased Tricuspid Annular Excursion in Athlete's Heart. Front Cardiovasc Med. 2015 Apr 30;2:8. doi: 10.3389/fcvm.2015.00008. eCollection 2015. PMID: 26664880; PMCID: PMC4671336.
Copy Download .nbib Format: NLM
Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Frontiers in cardiovascular medicine

Kamato D, Thach L, Bernard R, Chan V, Zheng W, Kaur H, Brimble M, Osman N, Little PJ.
PMID: 26664886
Front Cardiovasc Med. 2015 Mar 24;2:14. doi: 10.3389/fcvm.2015.00014. eCollection 2015.

G protein coupled receptors (GPCRs) are one of the major classes of cell surface receptors and are associated with a group of G proteins consisting of three subunits termed alpha, beta, and gamma. G proteins are classified into four...

Cite
Kamato D, Thach L, Bernard R, et al. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Front Cardiovasc Med. 2015;2:14doi: 10.3389/fcvm.2015.00014.
Kamato, D., Thach, L., Bernard, R., Chan, V., Zheng, W., Kaur, H., Brimble, M., Osman, N., & Little, P. J. (2015). Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Frontiers in cardiovascular medicine, 214. https://doi.org/10.3389/fcvm.2015.00014
Kamato, Danielle, et al. "Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11." Frontiers in cardiovascular medicine vol. 2 (2015): 14. doi: https://doi.org/10.3389/fcvm.2015.00014
Kamato D, Thach L, Bernard R, Chan V, Zheng W, Kaur H, Brimble M, Osman N, Little PJ. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11. Front Cardiovasc Med. 2015 Mar 24;2:14. doi: 10.3389/fcvm.2015.00014. eCollection 2015. PMID: 26664886; PMCID: PMC4671355.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3295 entries